BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34957163)

  • 1. The Assessment of the Innovativeness of a New Medicine in Italy.
    Fortinguerra F; Perna S; Marini R; Dell'Utri A; Trapanese M; Trotta F;
    Front Med (Lausanne); 2021; 8():793640. PubMed ID: 34957163
    [No Abstract]   [Full Text] [Related]  

  • 2. Using GRADE methodology to assess innovation of new medicinal products in Italy.
    Fortinguerra F; Tafuri G; Trotta F; Addis A
    Br J Clin Pharmacol; 2020 Jan; 86(1):93-105. PubMed ID: 31656055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking system.
    Galeone C; Bruzzi P; Jommi C
    BMJ Open; 2021 Jan; 11(1):e041259. PubMed ID: 33441356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EMA approval procedures and assessment of innovation by AIFA: a cross sectional analysis.].
    Lasala R
    Recenti Prog Med; 2021 Apr; 112(4):273-284. PubMed ID: 33877088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Innovative medicinal products: the new criteria of the Italian Medicines Agency.].
    Mammarella F; Tafuri G
    Recenti Prog Med; 2018 May; 109(5):261-262. PubMed ID: 29771247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value assessment of medicinal products by the Italian Medicines Agency (AIFA) and French National Authority for Health (HAS): Similarities and discrepancies.
    Xoxi E; Di Bidino R; Leone S; Aiello A; Prada M
    Front Med Technol; 2022; 4():917151. PubMed ID: 36134249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal Consistency.
    Jommi C; Galeone C
    Pharmacoecon Open; 2023 May; 7(3):373-381. PubMed ID: 36763319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical innovativeness index: methodological approach for assessing the value of medicines - a case study of oncology drugs.
    Gargano LP; Alvares-Teodoro J; de A Acurcio F; Guerra AA
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; ():1-10. PubMed ID: 38859799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do France, Germany, and Italy agree on the added therapeutic value of medicines?
    Casilli G; Lidonnici D; Jommi C; De Nigris M; Genazzani AA
    Int J Technol Assess Health Care; 2023 Aug; 39(1):e54. PubMed ID: 37580971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do patients value a hospital's innovativeness reputation? A multi-method approach to assess the relative importance of innovativeness reputation in patients' hospital choice.
    Gurtner S; Hietschold N; Vaquero Martín M
    Health Serv Manage Res; 2018 Aug; 31(3):138-153. PubMed ID: 29277121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skip pattern approach toward the early access of innovative anticancer drugs.
    Apolone G; Ardizzoni A; Biondi A; Bortolami A; Cardone C; Ciniselli CM; Conte P; Crippa C; de Braud F; Duca M; Gori S; Gritti G; Inno A; Luksch R; Lussana F; Maio M; Pasello G; Perrone F; Rambaldi A; Rossi G; Signorelli D; Soverini G; Valente M; Verderio P; Buzzetti G
    ESMO Open; 2021 Aug; 6(4):100227. PubMed ID: 34352703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolution of AIFA Registries to Support Managed Entry Agreements for Orphan Medicinal Products in Italy.
    Xoxi E; Facey KM; Cicchetti A
    Front Pharmacol; 2021; 12():699466. PubMed ID: 34456724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
    Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Something new every day: defining innovation and innovativeness in drug therapy.
    Aronson JK
    J Ambul Care Manage; 2008; 31(1):65-8. PubMed ID: 18162799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the opinions, experiences and individual innovativeness characteristics of operating room nurses on robotic surgery.
    Silveira Thomas Porto C; Catal E
    J Adv Nurs; 2021 Dec; 77(12):4755-4767. PubMed ID: 34423468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
    Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
    Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovativeness as an emergent property: a new alignment of comparative and experimental research on animal innovation.
    Griffin AS
    Philos Trans R Soc Lond B Biol Sci; 2016 Mar; 371(1690):. PubMed ID: 26926287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital innovativeness and organizational performance: evidence from English public acute care.
    Salge TO; Vera A
    Health Care Manage Rev; 2009; 34(1):54-67. PubMed ID: 19104264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining the Innovativeness of Nurses Who Engage in Activities That Encourage Innovative Behaviors.
    Leary M; Demiris G; Brooks Carthon JM; Cacchione PZ; Aryal S; Bauermeister JA
    Nurs Rep; 2024 Apr; 14(2):849-870. PubMed ID: 38651478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of hospitals' innovativeness on information system outsourcing decisions.
    Park JS
    Healthc Inform Res; 2014 Apr; 20(2):135-44. PubMed ID: 24872912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.